Global Ewing Sarcoma Therapeutics Research Report 2023 Featuring Abbott, AbbVie, Amgen, AstraZeneca, Baus - Benzinga
| LLY Stock | MXN 16,057 635.05 4.12% |
Slightly above 55% of Eli Lilly's investors are presently thinking to get in. The analysis of current outlook of investing in Eli Lilly and suggests that some traders are interested regarding Eli Lilly's prospects. Eli Lilly's investing sentiment can be driven by a variety of factors including economic data, Eli Lilly's earnings reports, geopolitical events, and overall market trends.
Eli |
Global Ewing Sarcoma Therapeutics Research Report 2023 Featuring Abbott, AbbVie, Amgen, AstraZeneca, Baus Benzinga
Read at news.google.com
 |
Eli Lilly Fundamental Analysis
We analyze Eli Lilly's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eli Lilly using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eli Lilly based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Eli Lilly is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Eli Lilly Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eli Lilly stock to make a market-neutral strategy. Peer analysis of Eli Lilly could also be used in its relative valuation, which is a method of valuing Eli Lilly by comparing valuation metrics with similar companies.
Peers
Eli Lilly Related Equities
| MLM | Martin Marietta | 0.00 |
| ||
| GNW | Genworth Financial | 0.00 |
| ||
| SPORTS | Grupo Sports | 0.31 |
| ||
| LUV | Southwest Airlines | 0.75 |
| ||
| CVS | CVS Health | 0.99 |
| ||
| AMP | Ameriprise Financial | 1.31 |
| ||
| HOTEL | Grupo Hotelero | 2.26 |
|
Additional Tools for Eli Stock Analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.